AnalystsKambiz YazdiKambiz Yazdi's Stock Forecasts
AnalystsKambiz Yazdi
Sectors:
Industries:
Analyst Ranking
Top 34%
#1658 out of 4995 analysts
Average Return
+31.74%
Win Rate
71%5 out of 7
Risk vs Reward
Poor
Good
Kambiz Yazdi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +213.27% | $15.15 | $47.46 | 2023-06-02 - 2024-05-31 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +49.53% | $10.69 | $15.99 | 2024-08-28 - 2025-08-22 | Strong Buy |
Eyepoint Pharmaceuticals IncEYPT | +34.13% | $8.82 | $11.83 | 2024-08-28 - 2025-08-22 | Strong Buy |
Avalo Therapeutics IncAVTX | +15.69% | $8.54 | $9.88 | 2025-03-25 - 2025-08-22 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +3.20% | $15.49 | $15.99 | 2025-03-11 - 2025-08-22 | Strong Buy |
Kambiz Yazdi Analyst Color
Get additional color on Kambiz Yazdi's coverage of popular stocks
Kambiz Yazdi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $23.00 | +132.79% | Initiates Coverage On | 5 months ago |
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $19.00 | +18.86% | Maintains | 5 months ago |
Eyepoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $15.00 | +26.80% | Initiates Coverage On | a year ago |
Pmv Pharmaceuticals IncPMVP | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $128.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.